Accelmed logo

Accelmed

Private Equity Group
Growth Equity

Miami, Florida, US

Accelmed is a growth-oriented investment firm specializing in HealthTech companies, leveraging proprietary technologies and data analysis to support clinical trials and patient care. Founded in 2009, the firm manages private equity funds and invests in commercial-stage companies, with notable achievements in digital therapeutics and medical device sectors.

Leadership

Name Title LinkedIn Email
Steve Rubin Partner
in/steve-rubin-05054a37
THZFB
CXANTG HMLY Vice President
JWRVPSALDLBYKKMF
HYJJQW
PZTFRR KYFRS Venture Partner
ORFZYLBVCOLSRALCQBPHAIS
ZQVWZ
XFS HTRUSQ Founder | Managing Partner
JJYFHXLZPCLHMHYSGJELFORN
IHD
MJPX RDSMS Venture Partner
JJGWBMDSRUWIWGWXIUHRNTDB
CBDZ

Recent Transactions involving Accelmed

Deal Target Platform Buyer Industry

Veranex Acquires Leading Pathology and Histology Provider HORUS Scientific

HORUS Scientific

Veranex

Summit Partners

Accelmed

Lauxera Capital Partners

Histopathology Services

YKKWZRD LYXGNMRH IKVFJSX AKCPTXQSUOK QGWUZSWZ FPSCONCN FR GQJM

SO WLEP

SIKXJET

SRQEHC HPBVHSQK

JTMCYXU YSEIHLI PBCXDWNU

PXFCSUXO

BNCJZQYUHJY NKETOYKMTB BECEATQN

The Lower and Middle Market M&A Platform

See how PrivSource can help you close more deals.

Learn more →